Research theme for competitive and other funds (8):
2015 - 2018 Lipid and steroid metabolism and prostate cancer using imaging mass-spectrometry
2013 - 2017 Circadian variation of serum hormone concentration in relation with serum melatonin level and tissue clock gene expression in patients receiving prostate needle biopsy
2010 - 2012 Tissue hormone determination and prostate cancer
2007 - 2008 The effect that a androgen gives to a bladder function. -The examination mainly on the blood vessel.
2005 - 2007 Genetic analysis of prostate cancer : identification of susceptibility gene in 1p36 and 8p23 loci
2004 - 2005 Regulatory mechanisms of blood flow in prostate gland
2003 - 2004 Genetic analysis of prostate cancer : comprehensive assessment of genetic polymorphisms and application to genetic diagnosis
2002 - 2004 Prediction of hormone refractory recurrence of prostate cancer by androgen receptor specific coactivator p120β
Show all
Papers (342):
Yoshitaka Sekine, Daisuke Oka, Akira Ohtsu, Hiroshi Nakayama, Takeshi Miyao, Yoshiyuki Miyazawa, Seiji Arai, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, et al. The combination of poly(ADP-ribose) polymerase inhibitor and statin inhibits the proliferation of human castration-resistant and taxane-resistant prostate cancer cells in vitro and in vivo. BMC cancer. 2025. 25. 1. 521-521
Akira Ohtsu, Seiji Arai, Yuji Fujizuka, Yoshiyuki Miyazawa, Masashi Nomura, Yoshitaka Sekine, Hidekazu Koike, Hiroshi Matsui, Yasuhiro Shibata, Kazuto Ito, et al. Predictive models of long-term survival outcomes following radical cystectomy. Cancer Medicine. 2023
Yoshiyuki Miyazawa, Akira Ohtsu, Daisuke Oka, Tomomi Saito, Hiroshi Nakayama, Sota Kurihara, Takeshi Miyao, Takahiro Syuto, Masashi Nomura, Yoshitaka Sekine, et al. CONSIDERATION OF CORRELATION BETWEEN CHANGES IN SERUM ADRENAL ANDROGEN LEVELS AND LOWER URINARY TRACT SYMPTOMS IN PROSTATE CANCER PATIENTS WITH ADMINISTRATION OF GNRH ANTAGONIST. JOURNAL OF UROLOGY. 2019. 201. 4. E1105-E1105
Impact of Pre-treatment Prostate Tissue Androgen Content on the Prediction of Future Castration-resistant Prostate Cancer Development in Patients Treated with Primary Androgen Deprivation Therapy
(10th International Congress of Andrology 2013)
Impact of Pre-treatment Prostate Tissue Androgen Content on the Prediction of Future Castration-resistant Prostate Cancer Development in Patients Treated with Primary Androgen Deprivation Therapy
(10th International Congress of Andrology 2013)
Impact of Pre-treatment Prostate Tissue Androgen Content on the Prediction of Future Castration-resistant Prostate Cancer Development in Patients Treated with Primary Androgen Deprivation Therapy
(15th International Congress on Hormonal Steroids and Hormones & Cancer 2012)